Clinical Trial Update: PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on PBGENE-DMD for Duchenne muscular dystrophy, outlining a Phase 1/2a safety and preliminary efficacy study that is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• PBGENE-DMD

Snippet

Sponsor: Precision BioSciences, Inc. | Conditions: Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING